<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 26 May 2026 07:05:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>NeoGenomics to Present New Research at ASCO Annual Meeting 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    FORT MYERS, Fla.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.neogenomics.com&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=NeoGenomics%2C+Inc.&amp;amp;index=1&amp;amp;md5=46c6a4e193d9b9a6a20835cfe21e5686&quot; shape=&quot;rect&quot;&gt;NeoGenomics, Inc.&lt;/a&gt; (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.asco.org%2Fannual-meeting&amp;amp;esheet=54541555&amp;amp;newsitemid=20260526677942&amp;amp;lan=en-US&amp;amp;anchor=2026+American+Society+of+Clinical+Oncology+%28ASCO%29+Annual+Meeting&amp;amp;index=2&amp;amp;md5=b1033d3674b137c24e30b1a4a28b44dd&quot; shape=&quot;rect&quot;&gt;2026 American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt;, May 29–June 2, 2026, in Chicago (booth #32130).

&lt;/p&gt;&lt;p&gt;
The abstracts demonstrate NeoGenomics' expanding capabilities across the company’s clinical oncology testing and data solutions, spanning hematologic malignancies, solid-tumor genomic profiling, the real-world impact of insurance coverage gaps</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/NeoGenomics+to+Present+New+Research+at+ASCO+Annual+Meeting+2026/26545753.html</guid>
   <pubDate>Tue, 26 May 2026 07:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216726</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07116439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21612337</category>
   	  </item>
  <item>
   <title>Form  8-K        NEOGENOMICS INC           For: May 21</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NEOGENOMICS+INC+++++++++++For%3A+May+21/26542009.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542009.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NEOGENOMICS+INC+++++++++++For%3A+May+21/26542009.html</guid>
   <pubDate>Fri, 22 May 2026 16:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	  </item>
  <item>
   <title>Form  8-K        NEOGENOMICS INC           For: May 21</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NEOGENOMICS+INC+++++++++++For%3A+May+21/26542009.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542009.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NEOGENOMICS+INC+++++++++++For%3A+May+21/26542009.html</guid>
   <pubDate>Fri, 22 May 2026 16:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01687242</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
  <item>
   <title>Greenland Mines to acquire Sarfartoq rare earths project for $35 million</title>
   <link>http://www.streetinsider.com/Corporate+News/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</link>
   <description>

&lt;p&gt;Greenland Mines Ltd (NASDAQ: GRML) announced it has entered into a definitive agreement to acquire Neo North Star Resources, Inc., owner of the Sarfartoq Rare Earths Project in southwest Greenland, for $35 million in cash and stock.&lt;/p&gt;

&lt;p&gt;The transaction includes $20 million in cash and $15 million in newly issued Greenland Mines common stock. Neo Performance Materials (TSX: NEO) will become a strategic shareholder and retain offtake rights for up to 60% of future Sarfartoq production.&lt;/p&gt;

&lt;p&gt;The Sarfartoq project contains a historic NI 43-101 Mineral Resource Estimate of 5.88 million tonnes of indicated resources grading 1.77% total rare earth oxides and 2.46</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Greenland+Mines+to+acquire+Sarfartoq+rare+earths+project+for+%2435+million/26532004.html</guid>
   <pubDate>Thu, 21 May 2026 08:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08421297</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.21734484</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33417578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GRML</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NEO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000288</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00495755</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03534383</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19806434</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54090960</category>
   	  </item>
 </channel>
</rss>
